logo
15:48 Dec 05

Amrutanjan Health Care Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
656.95
-10.05 (-1.51%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Amrutanjan Health Care Ltd. Financials

Amrutanjan Health Care Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
656.95
-10.05 (-1.51%)
15:48 Dec 05
Quality
image/svg+xml

68/100
High Financial Strength

Valuation
image/svg+xml

36/100
Mid Valuation

Technical

43/100
Technically Neutral

Strength

9

Weakness

3

Opportunity

1

Threats

0

16.77 %

ROE %

13.07 %

ROA %

19.61

EPS

86.22

BVPS

9.43 %

Net Profit Margin

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017
Net Sales
137.65 141.73 166.57 186.74 223.98
Operating Expenses +
120.23 119.92 142.81 155.95 194.96
Raw Material
59.17 56.14 62.49 66.46 88.51
Increase Decrease in Cost
0.98 0.87 0.26 0.58 -1.93
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
21.03 22.82 25.87 28.55 33.58
Miscellaneous Expenses
45.41 46.23 64.11 72.9 106.16
Operating Profit
17.42 21.81 23.76 30.79 29.02
Other Income
4.27 2.94 4.48 5.68 4.83
Depreciation
3.73 3.6 3.21 3.35 2.87
Interest
2.48 1.77 0.71 0.44 0.43
Profit before tax and exceptio..
15.47 19.38 24.32 32.68 30.55
Exceptional Items
0 0 0 0 2.69
PBT
15.47 19.38 24.32 32.68 33.24
Provision for Taxation
5.36 6.94 9.25 12.11 12.1
Net Profit
10.12 12.44 15.07 20.58 21.14
NET Profit after MI
10.12 12.44 15.07 20.58 21.14
EPS
6.92 8.51 10.31 14.08 14.47
Operating Profit Margin (%)
12.66 15.39 14.26 16.49 12.96
Net Profit Margin (%)
7.35 8.78 9.05 11.02 9.44

Amrutanjan Health Care Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 46.50 46.50 46.50 46.50 46.50 50.60
FII 2.40 2.40 2.30 2.30 2.30 1.60
Public 12.90 12.70 11.40 11.10 10.60 7.30
Others 38.20 38.40 39.80 40.10 40.60 40.50
Shareholder Shares Holding %
Research 360 logo
Download Our App On: